Exhibit 107
Calculation of Filing Fee Tables
FORM S-8
(Form Type)
YS Biopharma Co., Ltd.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
| Security Type | Security Class Title | Fee Calculation Rule | Amount Registered | Proposed Maximum Offering Price Per Unit | Maximum Aggregate Offering Price | Fee Rate | Amount of Registration Fee | |||||||||||||||||
| Equity | Ordinary Shares | Rule 457(c) and Rule 457(h) | 6,656,582 | (1) | $ | 1.39 | (2) | $ | 9,252,649 | $ | 0.0001102 | $ | 1,020 | |||||||||||
| Total Offering Amounts | $ | 9,252,649 | $ | 1,020 | ||||||||||||||||||||
| Total Fees Previously Paid | $ | 0 | ||||||||||||||||||||||
| Total Fee Offsets | $ | 0 | ||||||||||||||||||||||
| Net Fee Due | $ | 1,020 | ||||||||||||||||||||||
| (1) | Represents a total of 6,656,582 Ordinary Shares initially reserved for future issuance under the 2022 Plan. |
| (2) | Estimated in accordance with Rules 457(c) and (h) under the Securities Act, solely for the purpose of computing the amount of the registration fee and is equal to $1.39, the average of the high and low prices of the Ordinary Shares as reported on the Nasdaq Stock Market on July 3, 2023. |
